Cargando…
The Blockade of Tumoral IL1β-Mediated Signaling in Normal Colonic Fibroblasts Sensitizes Tumor Cells to Chemotherapy and Prevents Inflammatory CAF Activation
Heterotypic interactions between newly transformed cells and normal surrounding cells define tumor’s fate in incipient carcinomas. Once homeostasis has been lost, normal resident fibroblasts become carcinoma-associated fibroblasts, conferring protumorogenic properties on these normal cells. Here we...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125420/ https://www.ncbi.nlm.nih.gov/pubmed/34066976 http://dx.doi.org/10.3390/ijms22094960 |
_version_ | 1783693497099878400 |
---|---|
author | Díaz-Maroto, Natalia Guillén Garcia-Vicién, Gemma Polcaro, Giovanna Bañuls, María Albert, Nerea Villanueva, Alberto Molleví, David G. |
author_facet | Díaz-Maroto, Natalia Guillén Garcia-Vicién, Gemma Polcaro, Giovanna Bañuls, María Albert, Nerea Villanueva, Alberto Molleví, David G. |
author_sort | Díaz-Maroto, Natalia Guillén |
collection | PubMed |
description | Heterotypic interactions between newly transformed cells and normal surrounding cells define tumor’s fate in incipient carcinomas. Once homeostasis has been lost, normal resident fibroblasts become carcinoma-associated fibroblasts, conferring protumorogenic properties on these normal cells. Here we describe the IL1β-mediated interplay between cancer cells and normal colonic myofibroblasts (NCFs), which bestows differential sensitivity to cytotoxic drugs on tumor cells. We used NCFs, their conditioned media (CM), and cocultures with tumor cells to characterize the IL1β-mediated crosstalk between both cell types. We silenced IL1β in tumor cells to demonstrate that such cells do not exert an influence on NCFs inflammatory phenotype. Our results shows that IL1β is overexpressed in cocultured tumor cells. IL1β enables paracrine signaling in myofibroblasts, converting them into inflammatory-CAFs (iCAF). IL1β-stimulated-NCF-CM induces migration and differential sensitivity to oxaliplatin in colorectal tumor cells. Such chemoprotective effect has not been evidenced for TGFβ1-driven NCFs. IL1β induces the loss of a myofibroblastic phenotype in NCFs and acquisition of iCAF traits. In conclusion, IL1β-secreted by cancer cells modify surrounding normal fibroblasts to confer protumorogenic features on them, particularly tolerance to cytotoxic drugs. The use of IL1β-blocking agents might help to avoid the iCAF traits acquisition and consequently to counteract the protumorogenic actions these cells. |
format | Online Article Text |
id | pubmed-8125420 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81254202021-05-17 The Blockade of Tumoral IL1β-Mediated Signaling in Normal Colonic Fibroblasts Sensitizes Tumor Cells to Chemotherapy and Prevents Inflammatory CAF Activation Díaz-Maroto, Natalia Guillén Garcia-Vicién, Gemma Polcaro, Giovanna Bañuls, María Albert, Nerea Villanueva, Alberto Molleví, David G. Int J Mol Sci Article Heterotypic interactions between newly transformed cells and normal surrounding cells define tumor’s fate in incipient carcinomas. Once homeostasis has been lost, normal resident fibroblasts become carcinoma-associated fibroblasts, conferring protumorogenic properties on these normal cells. Here we describe the IL1β-mediated interplay between cancer cells and normal colonic myofibroblasts (NCFs), which bestows differential sensitivity to cytotoxic drugs on tumor cells. We used NCFs, their conditioned media (CM), and cocultures with tumor cells to characterize the IL1β-mediated crosstalk between both cell types. We silenced IL1β in tumor cells to demonstrate that such cells do not exert an influence on NCFs inflammatory phenotype. Our results shows that IL1β is overexpressed in cocultured tumor cells. IL1β enables paracrine signaling in myofibroblasts, converting them into inflammatory-CAFs (iCAF). IL1β-stimulated-NCF-CM induces migration and differential sensitivity to oxaliplatin in colorectal tumor cells. Such chemoprotective effect has not been evidenced for TGFβ1-driven NCFs. IL1β induces the loss of a myofibroblastic phenotype in NCFs and acquisition of iCAF traits. In conclusion, IL1β-secreted by cancer cells modify surrounding normal fibroblasts to confer protumorogenic features on them, particularly tolerance to cytotoxic drugs. The use of IL1β-blocking agents might help to avoid the iCAF traits acquisition and consequently to counteract the protumorogenic actions these cells. MDPI 2021-05-07 /pmc/articles/PMC8125420/ /pubmed/34066976 http://dx.doi.org/10.3390/ijms22094960 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Díaz-Maroto, Natalia Guillén Garcia-Vicién, Gemma Polcaro, Giovanna Bañuls, María Albert, Nerea Villanueva, Alberto Molleví, David G. The Blockade of Tumoral IL1β-Mediated Signaling in Normal Colonic Fibroblasts Sensitizes Tumor Cells to Chemotherapy and Prevents Inflammatory CAF Activation |
title | The Blockade of Tumoral IL1β-Mediated Signaling in Normal Colonic Fibroblasts Sensitizes Tumor Cells to Chemotherapy and Prevents Inflammatory CAF Activation |
title_full | The Blockade of Tumoral IL1β-Mediated Signaling in Normal Colonic Fibroblasts Sensitizes Tumor Cells to Chemotherapy and Prevents Inflammatory CAF Activation |
title_fullStr | The Blockade of Tumoral IL1β-Mediated Signaling in Normal Colonic Fibroblasts Sensitizes Tumor Cells to Chemotherapy and Prevents Inflammatory CAF Activation |
title_full_unstemmed | The Blockade of Tumoral IL1β-Mediated Signaling in Normal Colonic Fibroblasts Sensitizes Tumor Cells to Chemotherapy and Prevents Inflammatory CAF Activation |
title_short | The Blockade of Tumoral IL1β-Mediated Signaling in Normal Colonic Fibroblasts Sensitizes Tumor Cells to Chemotherapy and Prevents Inflammatory CAF Activation |
title_sort | blockade of tumoral il1β-mediated signaling in normal colonic fibroblasts sensitizes tumor cells to chemotherapy and prevents inflammatory caf activation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125420/ https://www.ncbi.nlm.nih.gov/pubmed/34066976 http://dx.doi.org/10.3390/ijms22094960 |
work_keys_str_mv | AT diazmarotonataliaguillen theblockadeoftumoralil1bmediatedsignalinginnormalcolonicfibroblastssensitizestumorcellstochemotherapyandpreventsinflammatorycafactivation AT garciaviciengemma theblockadeoftumoralil1bmediatedsignalinginnormalcolonicfibroblastssensitizestumorcellstochemotherapyandpreventsinflammatorycafactivation AT polcarogiovanna theblockadeoftumoralil1bmediatedsignalinginnormalcolonicfibroblastssensitizestumorcellstochemotherapyandpreventsinflammatorycafactivation AT banulsmaria theblockadeoftumoralil1bmediatedsignalinginnormalcolonicfibroblastssensitizestumorcellstochemotherapyandpreventsinflammatorycafactivation AT albertnerea theblockadeoftumoralil1bmediatedsignalinginnormalcolonicfibroblastssensitizestumorcellstochemotherapyandpreventsinflammatorycafactivation AT villanuevaalberto theblockadeoftumoralil1bmediatedsignalinginnormalcolonicfibroblastssensitizestumorcellstochemotherapyandpreventsinflammatorycafactivation AT mollevidavidg theblockadeoftumoralil1bmediatedsignalinginnormalcolonicfibroblastssensitizestumorcellstochemotherapyandpreventsinflammatorycafactivation AT diazmarotonataliaguillen blockadeoftumoralil1bmediatedsignalinginnormalcolonicfibroblastssensitizestumorcellstochemotherapyandpreventsinflammatorycafactivation AT garciaviciengemma blockadeoftumoralil1bmediatedsignalinginnormalcolonicfibroblastssensitizestumorcellstochemotherapyandpreventsinflammatorycafactivation AT polcarogiovanna blockadeoftumoralil1bmediatedsignalinginnormalcolonicfibroblastssensitizestumorcellstochemotherapyandpreventsinflammatorycafactivation AT banulsmaria blockadeoftumoralil1bmediatedsignalinginnormalcolonicfibroblastssensitizestumorcellstochemotherapyandpreventsinflammatorycafactivation AT albertnerea blockadeoftumoralil1bmediatedsignalinginnormalcolonicfibroblastssensitizestumorcellstochemotherapyandpreventsinflammatorycafactivation AT villanuevaalberto blockadeoftumoralil1bmediatedsignalinginnormalcolonicfibroblastssensitizestumorcellstochemotherapyandpreventsinflammatorycafactivation AT mollevidavidg blockadeoftumoralil1bmediatedsignalinginnormalcolonicfibroblastssensitizestumorcellstochemotherapyandpreventsinflammatorycafactivation |